General Information of the Compound
Compound ID
CP0412826
Compound Name
3-(3-chlorobenzyl)-1H-pyrazole-5-carboxylic acid
    Show/Hide
Synonyms
1H-Pyrazole-3-carboxylic acid, 5-[(3-chlorophenyl)methyl]-
3-(3-chlorobenzyl)-1H-pyrazole-5-carboxylic acid
5-(3-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid
5-(3-Chlorobenzyl)-1H-pyrazole-3-carboxylic acid
5-meta-chlorobenzyl-3-carboxyl-pyrazole
595610-55-2
AKOS030620128
BDBM50216550
CHEMBL394441
CTK1D9284
DTXSID30472377
SCHEMBL569462
    Show/Hide
Structure
Formula
C11H9ClN2O2
Molecular Weight
236.658
Canonical SMILES
OC(=O)c1cc(Cc2cccc(Cl)c2)[nH]n1
    Show/Hide
InChI
InChI=1S/C11H9ClN2O2/c12-8-3-1-2-7(4-8)5-9-6-10(11(15)16)14-13-9/h1-4,6H,5H2,(H,13,14)(H,15,16)
    Show/Hide
InChIKey
UYMDSFKYOCEPFN-UHFFFAOYSA-N
Physicochemical Property
logP
2.3521
Rotatable Bonds
3
Heavy Atom Count
16
Polar Areas
65.98
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11776293
SID: 16885730
ChEMBL ID
CHEMBL394441
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01282, Hydroxycarboxylic acid receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
IC50 = 4200 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 5-(3-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid )
Drug Name 5-(3-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid
Target(s)
Nicotinic acid receptor (HCAR2)
Inhibitor